Sojeong Lee

Sojeong Lee

Auto-generated profile, based on publicly available information

Sojeong Lee

Department of Chemical & Biomolecular Engineering, Yonsei University, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SLSojeong Lee
Sojeong Lee
EKEunjung Kim
Eunjung Kim
CMChae-Eun Moon
Chae-Eun Moon
CPChaewon Park
Chaewon Park
JLJong-Woo Lim
Jong-Woo Lim
SHSeungjoo Haam
Seungjoo Haam
Accurate diagnosis of Alzheimer’s disease (AD) in its earliest stage can prevent the disease and delay the symptoms. Therefore, more sensitive, non-invasive, and simple screening tools are required for the early diagnosis and monitoring of AD. Here, we design a self-assembled nanoparticle-mediated amplified fluorogenic immunoassay (SNAFIA) consisting of magnetic and fluorophore-loaded polymeric nanoparticles. Using a discovery cohort of 21 subjects, proteomic analysis identifies adenylyl cyclase-associated protein 1 (CAP1) as a potential tear biomarker. The SNAFIA demonstrates a low detection limit (236 aM), good reliability (R2 = 0.991), and a wide analytical range (0.320–1000 fM) for CAP1 in tear fluid. Crucially, in the verification phase with 39 subjects, SNAFIA discriminates AD patients from healthy controls with 90% sensitivity and 100% specificity in under an hour. Utilizing tear fluid as a liquid biopsy, SNAFIA could potentially aid in long-term care planning, improve clinical trial efficiency, and accelerate therapeutic development for AD.

27 May 2025 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
SPSungjae Park
Sungjae Park
DSDongmin Shin
Dongmin Shin
SLSojeong Lee
Sojeong Lee
JPJungwoo Park
Jungwoo Park
SHSeungjoo Haam
Seungjoo Haam
JHJungho Hwang
Jungho Hwang